As we step into 2025, the pharmacy profession finds itself navigating a rapidly changing landscape. Challenges like pharmacy deserts, workforce development, supply chain issues, and PBM reform are reshaping the industry. How will we respond?
A recent Wall Street Journal article exposes a troubling issue: the extreme variability in pricing for generic medications. These drugs are manufactured by different companies but sold at widely differing prices. Medicare’s payments for these medications, which vary across 2,200 different price points, highlight a fragmented and inefficient market.
The variability in pricing for generic medications isn’t simply a matter of poor negotiation or inefficiency. It’s a structural issue embedded in the market’s reliance on fragmented supply chains.
Statins, including popular medications like Lipitor (atorvastatin) and Crestor (rosuvastatin), are among the most commonly prescribed drugs in the United States. Their ability to lower LDL cholesterol (the “bad” type) has undoubtedly saved countless lives by reducing the risk of heart attacks and strokes.
However, as a pharmacist with more than 20 years of experience, I’ve seen firsthand that every powerful medication comes with trade-offs. One of the most overlooked consequences of long-term statin use is the depletion of a crucial nutrient in the body: Coenzyme Q10 (CoQ10).
GLP-1 drugs for weight loss are popular, effective, and expensive. How should health plans handle increasing prescription costs driven by these medications? It’s complicated, but the bottom line is that although weight loss has many health benefits, the costs of these medications today negate those benefits from a cost standpoint. Read on for more.
Existing payment models for community pharmacies are based on prescription drug sales, a form of fee-for-service reimbursement, which may not sufficiently incentivize the implementation or expansion of pharmacist-based care. The Membership Pharmacy Model may represent a viable alternative by generating pharmacy revenue through membership fees, not prescription drug sales.
Pharmacy has changed dramatically. Although it’s (unfortunately) a volume business, pharmacies often struggle with having enough staff to safely care for their patients. In this survey, we hope to gauge what staffing challenges exist in U.S. pharmacies, as well as how to help address them.
Access to health care, especially in rural areas, is often a challenge. Although rural health care is threatened by a wave of rural hospital closures, a recent analysis published in the Journal of the American Pharmacy Association showed that nearly half of Americans live within one mile of a community pharmacy, while 96.5% live within 10 miles of one. Pharmacists have long been the most accessible front-line health care professionals for most people – and that’s even more true as technology advances an ever-evolving health care landscape. Today, telehealth and virtual pharmacy services have emerged as pivotal solutions to address the challenges of medication access, prescription adherence and convenience.
The pharmaceutical industry is at a crossroads, with Pharmacy Benefit Managers (PBMs) playing a central role in driving up prescription drug costs. As revealed in the New York Times article “How PBMs Are Driving Up Prescription Drug Costs,” these middlemen have become a fast-growing and profitable industry, often at the expense of patients and the overall health care system. This paper aims to empower patients, providers and payers with actionable strategies to combat corrupt PBM practices and work toward a more transparent, equitable and patient-centered pharmacy future.
Prescription transfers between pharmacy chains are common, but for many patients, the process is more complex and time-consuming than it should be. Patients must locate their prescriptions at the incorrect pharmacy, contact the correct pharmacy, and request a verbal transfer. Although prescriptions can be faxed, the correct pharmacy must still call the incorrect pharmacy to request that fax. Furthermore, many states require that only pharmacists can transfer prescriptions, leaving technicians unable to assist. This restriction poses significant challenges. Currently, just 17 states allow technicians to take verbal orders for new or transferred prescriptions. In most states, pharmacists are solely responsible for handling prescription transfers, adding to their already heavy workload and increasing the risk of errors and delays.